What is Kyverna Therapeutics, Inc.'s investing cash flow?

Kyverna Therapeutics, Inc. (KYTX) reported investing cash flow of -$50.2M in Q1 2026.

How has Kyverna Therapeutics, Inc.'s investing cash flow changed year-over-year?

Kyverna Therapeutics, Inc.'s investing cash flow decreased by 1000.0% year-over-year, from $5.58M to -$50.2M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Kyverna Therapeutics, Inc. KYTX Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

Gilead SciencesGILD

$1.77B+527%

Climb Bio, Inc.CLYM

-$12.96M+69.7%

Artiva Biotherapeutics, Inc.ARTV

$15.32M+53.6%

Iovance Biotherapeutics, Inc.IOVA

$11.39M-28.2%

Viridian Therapeutics, Inc.VRDN

$77.26M-22.8%

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s investing cash flow?: Kyverna Therapeutics, Inc. (KYTX) reported investing cash flow of -$50.2M in Q1 2026.
How has Kyverna Therapeutics, Inc.'s investing cash flow changed year-over-year?: Kyverna Therapeutics, Inc.'s investing cash flow decreased by 1000.0% year-over-year, from $5.58M to -$50.2M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.